Insider Transactions in Q2 2024 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 01
2024
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.14%
|
$570,000
$38.46 P/Share
|